Elastin, the main component of arterial extracellular matrix, was thought
to have a purely structural role. Consistent with this view, elastin
hemizygous mice maintain arterial extensibility by increasing the number
of elastic lamellae during development. However, mice lacking elastin die
of obstructive arterial pathology. This pathology results from
subendothelial proliferation and reorganization of smooth muscle,
cellular changes similar to those observed in atherosclerosis. Thus,
elastin is a molecular determinant of arterial morphogenesis and likely
plays a central role in vascular disease. Mice which are heterozygous and
null for the elastin gene have been developed. These mice are extremely
useful for screening for drugs useful for treating persons with
atherosclerosis, hypertension, SVAS or other vascular diseases.